The American Society of Anesthesiologists (ASA) Physical Status classification system is one of the most widely used tools in perioperative medicine. Created in the 1940s, its six-tier scale — from ASA I (healthy patient) through ASA VI (brain-dead organ donor) — categorizes patients by their pre-operative physical health status as a proxy for anesthetic risk. Despite its near-universal adoption, the system has attracted substantive criticism regarding its reliability, utility, and application in clinical practice.
The Classification System
The ASA scale classifies patients as follows:
- ASA I: Normal healthy patient
- ASA II: Patient with mild systemic disease
- ASA III: Patient with severe systemic disease
- ASA IV: Patient with severe systemic disease that is a constant threat to life
- ASA V: Moribund patient not expected to survive without the operation
- ASA VI: Brain-dead patient declared for organ donation
For procedures performed under emergency conditions, an "E" is appended (e.g., ASA III-E).
The Core Problem: Subjectivity
The most persistent criticism of the ASA classification is its inherent subjectivity. Without clear, objective criteria for assigning scores — particularly in the critical middle range (ASA II vs. III vs. IV) — different providers assign different scores to identical patients.
This was documented as early as 1978, when a study found that among 10 test cases reviewed by 235 anesthetists, 4 were classified inconsistently across a majority of reviewers. A 1997 Finnish survey found that one in nine respondents voluntarily stated that the ASA physical status "helps little or not at all" with their daily work — a striking admission from within the specialty.
Geographic and Institutional Variation
A 2002 study from Hong Kong found that ASA classification varied systematically by provider training location and hospital type. Providers trained in different national healthcare systems applied the scale differently — suggesting that interpretations are shaped by local culture and norms rather than objective clinical criteria alone.
More concerning, the same study raised the possibility that ASA scores might be subject to deliberate manipulation for financial gain — given that higher ASA scores can justify different billing categories or influence case complexity documentation in some healthcare payment contexts.
Improvement Efforts: 2020 Revisions
Recognizing these limitations, the American Society of Anesthesiologists revised the classification in 2020 by adding specific clinical examples for each category, including dedicated examples for pediatric and obstetric patients. The goal was to reduce inter-rater variability by grounding the scale in concrete clinical presentations.
While these additions improved consistency in some studies, inter-rater variability has not been eliminated — particularly at the ASA II/III boundary where clinical complexity is most ambiguous.
What the System Does Well
Despite its limitations, the ASA classification continues to fulfill its original intended purpose effectively: it "works extremely well for its intended purpose, which is to allow comparison of large groups of patients" in research and quality improvement contexts. When applied to population-level analyses — comparing outcomes across institutions, procedures, or time periods — the aggregate distribution of ASA scores provides meaningful signal even if individual assignments are somewhat variable.
The system also serves as a common communication shorthand among anesthesia providers and surgeons — a brief, shared vocabulary for conveying a patient's overall physiological reserve at handoffs and in case planning.
The Path Forward
The ASA classification system is unlikely to be replaced given its deep entrenchment in clinical practice and research methodology. But the criticisms are valid and worth taking seriously. Proposals for improvement include developing more objective scoring criteria, validating scores against physiologic measures, and supplementing the scale with condition-specific comorbidity indices for higher-risk populations. The goal is a tool that is both practical and reliable — a combination the current version does not fully achieve.